Phathom Pharmaceuticals Presents New Data Evaluating First-in-Class Potassium-Competitive Acid Blocker (PCAB) Vonoprazan as Novel On-Demand Treatment in NERD at American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting - Phathom Pharmaceuticals (NASDAQ:PHAT) - Press Release

FLORHAM PARK, N.J., Oct. 23, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. PHAT, a biopharmaceutical company focused on developing and commer

Related Keywords

Japan ,Ohio ,United States ,Canada ,Ronnie Fass ,Carmelo Scarpignato ,Nick Benedetto ,Azmi Nabulsi ,Division Of Gastroenterology ,Linkedin ,Twitter ,Consensus Group ,Digestive Health Center At Metrohealth In Cleveland ,Company Annual Report On Form ,Exchange Commission ,American College Of Gastroenterology ,Phathom Pharmaceuticals Inc ,Phathom Pharmaceuticals ,World Organization For Esophageal Diseases ,American College ,Scientific Meeting ,Digestive Health Center ,Chief Operating Officer ,Clinical Pharmacology ,United Campus ,General Secretary ,World Organization ,Esophageal Diseases ,New Drug Application ,Non Erosive Gastroesophageal Reflux Disease ,Cutaneous Adverse Reactions ,Diagnostic Investigations ,Neuroendocrine Tumors ,Precautions Due ,Clarithromycin Component ,Fetal Toxicity ,Prescribing Information ,Hepatic Impairment ,Annual Report ,Private Securities Litigation Reform Act ,